Workshop: Kinase Ligand Design

webinar

Thu, 01 Feb 2024, 16:00 CET (Berlin)

Dr. Alexander Neumann, BioSolveIT

Workshop: Kinase Ligand Design

Kinases stand out as a popular focus in drug development. Their popularity is evident from the numerous FDA approvals granted to compounds targeting these specific proteins. The associated design process often integrates computational approaches such as molecular modeling and structure-based drug design, reflecting the dynamic and evolving landscape of kinase-targeted drug development.

This BioSolveIT workshop is dedicated to elucidating the basics of selective kinase inhibitor design, as well as the application of advanced techniques to optimize lead structures. Encompassing both the 3D structure-based and the 2D ligand-based realms, we will present and discuss several examples illustrating idea generation methods for hinge binders and the adjacent core regions. These methods will include fragment-based growing (FBDD), scaffold hopping, Chemical Space exploration involving trillions of possibilities, and various other strategies facilitated by BioSolveIT tools.

Drug discovery beginners, veterans, and medicinal chemistry enthusiasts are invited to join this highly informative workshop and the subsequent discussion.

Participants can request a certificate of attendance to confirm their completion of the event to furthering their knowledge and skills in the specified subject matter.

Current news

Enamine's REAL Space October Update
October 8, 2024 12:23 CEST
The October update of Enamine’s REAL Space brings an impressive increase, now offering over 70 billion accessible, drug-like products, compared to 48 billion previously. With a total of 167 reactions now based on in-house knowledge and building blocks, the expansion continues to strengthen one of the largest commercially available compound collections...
Read on
category
Challenge
Winner of the Scientific Challenge Fall 2023: Jeevan Patra with Falcipain Inhibitors
September 20, 2024 10:19 CEST
We are excited to announce that Jeevan Patra is the winner of the BioSolveIT Scientific Challenge Fall 2023. Patra’s research targets Falcipain, a key enzyme in malaria, by identifying selective inhibitors from the Malaria Box, a collection of potent antimalarial candidates by the Medicines for Malaria Venture, Switzerland. With rising...
Read on
2025 Herman Skolnik Award Goes to Prof. Dr. Matthias Rarey
September 19, 2024 17:08 CEST
BioSolveIT is proud to put forth that Prof. Dr. Matthias Rarey, co-founder and a key contributor to the company’s success, shall be recognized with the 2025 Herman Skolnik Award by the American Chemical Society’s Division of Chemical Information (ACS CINF). This award honors his significant contributions to the field of...
Read on